Loading viewer...
investor_presentation
Format: PDF investor_presentation
SECOND QUARTER 2022 FINANCIAL RESULTSAUGUST 4, 2022©2022 Vertex Pharmaceuticals Incorporated 1
SECOND QUARTER 2022 FINANCIAL RESULTSAUGUST 4, 2022©2022 Vertex Pharmaceuticals Incorporated
12AGENDAIntroductionCharlie Wagner, Executive Vice President and Chief Financial OfficerCEO Perspective and Pipeline UpdateReshma Kewalramani, M.D., Chief Executive Officer and PresidentBusiness UpdateStuart Arbuckle, Executive Vice President and Chief Operating OfficerFinancial ResultsCharlie Wagner, Executive Vice President and Chief Financial Officer
Preview truncated — download the full document for the complete content.
investor_presentation
13 Pages
investor_presentation
20 Pages
Inogen, Inc.
investor_presentation
Uniti Group